Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding

被引:59
作者
Gelling, RW
Overduin, J
Morrison, CD
Morton, GJ
Frayo, RS
Cummings, DE
Schwartz, MW
机构
[1] Univ Washington, Harborview Med Ctr, Div Endocrinol, Dept Med, Seattle, WA 98104 USA
[2] Vet Affairs Puget Sound Healthcare Syst, Dept Med, Seattle, WA 98108 USA
关键词
D O I
10.1210/en.2004-0605
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma levels of the orexigenic hormone, ghrelin, decrease rapidly on nutrient ingestion and yet are paradoxically elevated in rats with hyperphagia induced by streptozotocin-induced diabetes (STZ-DM). In the current work, we investigated the mechanisms underlying the relationships among uncontrolled diabetes, food intake, and plasma ghrelin concentrations in an effort to clarify whether increased ghrelin signaling contributes to diabetic hyperphagia. Whereas food intake did not increase until d 3 after STZ administration, plasma ghrelin levels were increased by more than 2-fold ( P < 0.05) on d 1. As hyperphagia developed, however, plasma ghrelin levels declined steadily. Because this reduction of plasma ghrelin levels was reversed by matching food intake of STZ-DM rats to that of nondiabetic controls, our results demonstrated that the effect of uncontrolled diabetes to increase plasma ghrelin levels is partially offset by hyperphagic feeding. In addition, we found that although intragastric nutrient infusion rapidly and comparably decreased plasma ghrelin levels in both groups ( by 46 - 49%; P < 0.05), this effect was short lived in STZ-DM rats relative to nondiabetic controls ( 60 min vs. 120 min; P< 0.05). We further demonstrated that in rats with STZ-DM, food intake increased by 357% ( P < 0.05) in response to intracerebroventricular administration of ghrelin at a dose that was subthreshold for feeding effects in nondiabetic controls. Collectively, these findings demonstrate that uncontrolled diabetes increases both circulating ghrelin levels and behavioral sensitivity to ghrelin. Although plasma ghrelin levels fall in response to hyperphagic feeding, these findings support the hypothesis that increased ghrelin signaling contributes to the pathogenesis of diabetic hyperphagia.
引用
收藏
页码:4575 / 4582
页数:8
相关论文
共 54 条
[1]   Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin [J].
Asakawa, A ;
Inui, A ;
Kaga, T ;
Yuzuriha, H ;
Nagata, T ;
Ueno, N ;
Makino, S ;
Fujimiya, M ;
Niijima, A ;
Fujino, MA ;
Kasuga, M .
GASTROENTEROLOGY, 2001, 120 (02) :337-345
[2]  
Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrg862, 10.1038/nrn902]
[3]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[4]   SOME CHARACTERISTICS OF FEEDING DURING STREPTOZOTOCIN-INDUCED DIABETES IN RAT [J].
BOOTH, DA .
JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY, 1972, 80 (02) :238-&
[5]   Insulin, unlike food intake, does not suppress ghrelin in human subjects. [J].
Caixás, A ;
Bashore, C ;
Nash, W ;
Pi-Sunyer, FX ;
Laferrère, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1902-1906
[6]  
CAIXAS A, 2003, NEURON, V37, P649
[7]   Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein [J].
Chen, HY ;
Trumbauer, ME ;
Chen, AS ;
Weingarth, DT ;
Adams, JR ;
Frazier, EG ;
Shen, Z ;
Marsh, DJ ;
Feighner, SD ;
Guan, XM ;
Ye, Z ;
Nargund, RP ;
Smith, RG ;
Van Der Ploeg, LHT ;
Howard, AD ;
Macneil, DJ ;
Qian, S .
ENDOCRINOLOGY, 2004, 145 (06) :2607-2612
[8]   Roles for ghrelin in the regulation of appetite and body weight [J].
Cummings, DE ;
Shannon, MH .
ARCHIVES OF SURGERY, 2003, 138 (04) :389-396
[9]   A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans [J].
Cummings, DE ;
Purnell, JQ ;
Frayo, RS ;
Schmidova, K ;
Wisse, BE ;
Weigle, DS .
DIABETES, 2001, 50 (08) :1714-1719
[10]   Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans [J].
Date, Y ;
Kojima, M ;
Hosoda, H ;
Sawaguchi, A ;
Mondal, MS ;
Suganuma, T ;
Matsukura, S ;
Kangawa, K ;
Nakazato, M .
ENDOCRINOLOGY, 2000, 141 (11) :4255-4261